OR WAIT null SECS
November 03, 2021
Lonza is expanding its exosomes development and manufacturing capabilities with the acquisition of a service unit from Exosomics and a manufacturing facility from Codiak BioSciences.
November 02, 2021
Takeda’s acquisition of GammaDelta Therapeutics expands their immuno-oncology and innate immune cell therapy portfolio.
Aceragen’s acquisition of Arrevus adds key treatment candidates to its rare disease pipeline.
Following the acquisition, Avantor will have access to Masterflex’s various bioproduction operations.
October 29, 2021
The research collaboration between Sartorius and Matica Biotechnology will aim to optimize PAT technologies, automation software, and single-use platforms for large-scale viral vector production.
The $691 million deal will see Vertex use Mammoth’s systems to discover and develop in-vivo gene-editing therapies.
Merck’s agreement with the Medicines Patent Pool (MPP) aims to facilitate affordable global access for molnupiravir.
October 28, 2021
SGS’s new Antwerp, Belgium, clinical research site will house both clinical trial patients and good manufacturing practice drug manufacturing, and its Glasgow, UK, biosafety testing site now has increased testing capacity.
October 21, 2021
The $19 million contract will expand production capacity of Aptar’s Activ-Film technology, which is used in COVID-19 testing kits.
October 14, 2021
Aceto will acquire A&C Bio Buffer, including the company’s custom buffer and chemical blend portfolio.